$CATX
Perspective Therapeutics, Inc.

2012 Q2 Form 10-Q Financial Statement

#000114420412029499 Filed on May 15, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q2
Revenue $1.310M $1.317M $1.260M
YoY Change 3.97% -6.62% -5.97%
Cost Of Revenue $1.080M $1.113M $800.0K
YoY Change 35.0% 5.69% -30.43%
Gross Profit $230.0K $204.2K $460.0K
YoY Change -50.0% -42.86% 142.11%
Gross Profit Margin 17.56% 15.5% 36.51%
Selling, General & Admin $1.020M $834.8K $1.050M
YoY Change -2.86% -3.24% -8.7%
% of Gross Profit 443.48% 408.8% 228.26%
Research & Development $210.0K $132.2K $300.0K
YoY Change -30.0% -45.85% 172.73%
% of Gross Profit 91.3% 64.75% 65.22%
Depreciation & Amortization $260.0K $210.0K $240.0K
YoY Change 8.33% -47.5% 4.35%
% of Gross Profit 113.04% 102.83% 52.17%
Operating Expenses $1.170M $967.1K $1.220M
YoY Change -4.1% -7.97% -3.17%
Operating Profit -$940.0K -$762.9K -$760.0K
YoY Change 23.68% 10.01% -28.97%
Interest Expense -$260.0K $210.0K $50.00K
YoY Change -620.0% -161.76%
% of Operating Profit
Other Income/Expense, Net $210.0K
YoY Change -162.34%
Pretax Income -$1.200M -$550.0K -$710.0K
YoY Change 69.01% -46.6% -34.26%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.200M -$552.9K -$710.0K
YoY Change 69.01% -46.34% -34.26%
Net Earnings / Revenue -91.6% -41.97% -56.35%
Basic Earnings Per Share
Diluted Earnings Per Share -$40.53K -$18.76K -$26.89K
COMMON SHARES
Basic Shares Outstanding 29.32M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.670M $2.520M $2.110M
YoY Change 26.54% -5.62% 25.6%
Cash & Equivalents $2.673M $2.524M $2.112M
Short-Term Investments
Other Short-Term Assets $26.69K $170.0K $140.0K
YoY Change -80.93% -34.62% -46.15%
Inventory $444.3K $441.2K $749.8K
Prepaid Expenses
Receivables $865.1K $853.1K $792.8K
Other Receivables $0.00 $20.00K $430.0K
Total Short-Term Assets $4.136M $4.007M $4.222M
YoY Change -2.03% -12.33% 19.94%
LONG-TERM ASSETS
Property, Plant & Equipment $2.417M $2.592M $3.209M
YoY Change -24.68% -23.78% -18.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $301.7K $299.7K $277.2K
YoY Change 8.84% 57.71% 45.89%
Total Long-Term Assets $3.369M $3.584M $3.667M
YoY Change -8.12% -7.16% -17.04%
TOTAL ASSETS
Total Short-Term Assets $4.136M $4.007M $4.222M
Total Long-Term Assets $3.369M $3.584M $3.667M
Total Assets $7.505M $7.590M $7.889M
YoY Change -4.86% -9.96% -0.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $390.0K $350.0K $370.0K
YoY Change 5.41% 9.38% -7.5%
Accrued Expenses $260.0K $280.0K $400.0K
YoY Change -35.0% -9.68% -28.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $649.0K $626.1K $774.2K
YoY Change -16.17% -9.26% -23.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.040M $810.0K $660.0K
YoY Change 57.58% -7.95% 8.2%
Total Long-Term Liabilities $1.040M $810.0K $660.0K
YoY Change 57.58% -16.49% -10.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $649.0K $626.1K $774.2K
Total Long-Term Liabilities $1.040M $810.0K $660.0K
Total Liabilities $1.687M $1.439M $1.436M
YoY Change 17.47% -12.77% -17.92%
SHAREHOLDERS EQUITY
Retained Earnings -$48.23M -$47.03M -$44.75M
YoY Change 7.8%
Common Stock $30.95K $29.32K $26.44K
YoY Change 17.04%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.390K $8.390K $8.390K
YoY Change 0.0%
Treasury Stock Shares 13.20K shares 13.20K shares 13.20K shares
Shareholders Equity $5.818M $6.151M $6.453M
YoY Change
Total Liabilities & Shareholders Equity $7.505M $7.590M $7.889M
YoY Change -4.86% -9.96% -0.64%

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q2
OPERATING ACTIVITIES
Net Income -$1.200M -$552.9K -$710.0K
YoY Change 69.01% -46.34% -34.26%
Depreciation, Depletion And Amortization $260.0K $210.0K $240.0K
YoY Change 8.33% -47.5% 4.35%
Cash From Operating Activities -$630.0K -$810.0K -$610.0K
YoY Change 3.28% 55.77% -6.15%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K -$40.00K -$50.00K
YoY Change -40.0% -50.0% 400.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$30.00K -$40.00K -$50.00K
YoY Change -40.0% -50.0% 150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 790.0K 0.000 610.0K
YoY Change 29.51% -100.0% -777.78%
NET CHANGE
Cash From Operating Activities -630.0K -810.0K -610.0K
Cash From Investing Activities -30.00K -40.00K -50.00K
Cash From Financing Activities 790.0K 0.000 610.0K
Net Change In Cash 130.0K -850.0K -50.00K
YoY Change -360.0% 39.34% -93.42%
FREE CASH FLOW
Cash From Operating Activities -$630.0K -$810.0K -$610.0K
Capital Expenditures -$30.00K -$40.00K -$50.00K
Free Cash Flow -$600.0K -$770.0K -$560.0K
YoY Change 7.14% 75.0% -12.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
626107
CY2012Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
82912
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29316306 shares
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3475928
CY2012Q1 us-gaap Other Inventory Noncurrent
OtherInventoryNoncurrent
469758
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
299656
CY2012Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
41622
CY2012Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
86666
CY2012Q1 us-gaap Treasury Stock Value
TreasuryStockValue
8390
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47029779
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
168509
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
853097
CY2012Q1 us-gaap Assets
Assets
7590353
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
29316
CY2012Q1 us-gaap Inventory Net
InventoryNet
441194
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
40000
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29316306 shares
CY2012Q1 us-gaap Assets Current
AssetsCurrent
4006672
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2524397
CY2012Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
104905
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53159892
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
53612
CY2012Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
345818
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7590353
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
6151098
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29316306 shares
CY2012Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
708243
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2591649
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
193000000 shares
CY2012Q1 us-gaap Liabilities
Liabilities
1439255
CY2012Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2012Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
19475
CY2012Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
180996
CY2012Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
70711
CY2010Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2990744
CY2011Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
277182
CY2011Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
98159
CY2011Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8390
CY2011Q2 us-gaap Assets
Assets
7888895
CY2011Q2 us-gaap Common Stock Value
CommonStockValue
26443
CY2011Q2 us-gaap Inventory Net
InventoryNet
749849
CY2011Q2 us-gaap Liabilities Current
LiabilitiesCurrent
774198
CY2011Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
70706
CY2011Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44745833
us-gaap Investment Income Interest
InvestmentIncomeInterest
2888
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
944244
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34433
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3281800
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
42111
CY2011Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
141154
CY2011Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
792835
CY2011Q2 us-gaap Liabilities
Liabilities
1436379
CY2011Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2011Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3208911
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
193000000 shares
CY2011Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
425901
CY2011Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
180809
CY2011Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125014
us-gaap Gross Profit
GrossProfit
700943
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-105972
CY2011Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
108060
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26443118 shares
CY2011Q2 us-gaap Assets Current
AssetsCurrent
4221993
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2112254
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51180237
CY2011Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
63867
CY2011Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
372259
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7888895
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
6452516
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26443118 shares
CY2011Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
662181
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
215027
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
205947
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1808368
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7974
us-gaap Share Based Compensation
ShareBasedCompensation
68622
us-gaap Interest And Debt Expense
InterestAndDebtExpense
193500
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-80661
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
571
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
2250000
us-gaap Net Income Loss
NetIncomeLoss
-2130216
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
66388
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
374317
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2138190
us-gaap Adjustment For Amortization
AdjustmentForAmortization
206038
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
105401
us-gaap Depreciation And Amortization
DepreciationAndAmortization
668171
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
385318
us-gaap Operating Income Loss
OperatingIncomeLoss
-2196604
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-7293
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3982743
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
36000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
368781
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
485184
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14521
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-163032
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47128
us-gaap Operating Expenses
OperatingExpenses
2897547
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
257000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-114412
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1784933
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2399524
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
38334
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
isr Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
24709541 shares
isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
-19386
isr Supplemental Common Stock Warrant Liability
SupplementalCommonStockWarrantLiability
1724000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
ISR
dei Entity Registrant Name
EntityRegistrantName
ISORAY, INC.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
dei Entity Central Index Key
EntityCentralIndexKey
0000728387
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
us-gaap Gross Profit
GrossProfit
469461
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1352
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69087
us-gaap Investment Income Interest
InvestmentIncomeInterest
599
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
877549
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50006
us-gaap Cost Of Goods Sold
CostOfGoodsSold
3289982
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
46062
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
187
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
2592549
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
40244
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
50000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1824219
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7974
us-gaap Share Based Compensation
ShareBasedCompensation
99568
us-gaap Interest And Debt Expense
InterestAndDebtExpense
6323
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26441
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="FONT: 10pt Times New Roman, Times, Serif"> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="WIDTH: 0.5in"><b>2.</b></td> <td><b>New Accounting Pronouncements</b></td> </tr> </table> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>&#xA0;</b></p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the &#x201C;FASB&#x201D;) or other standards setting bodies that are adopted by us as of the specified effective dates. Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.</p> </div>
us-gaap Net Income Loss
NetIncomeLoss
-2283946
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
373371
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
573212
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-406426
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2291920
us-gaap Adjustment For Amortization
AdjustmentForAmortization
26577
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
643262
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
318064
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
42900
us-gaap Operating Income Loss
OperatingIncomeLoss
-2657317
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13617
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
412143
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
12206
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3759443
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-68060
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-11493
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
161103
us-gaap Operating Expenses
OperatingExpenses
3126778
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
379095
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-54303
CY2011Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-163000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1726017
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2305449
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
isr Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
28128125 shares
isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
10256
isr Supplemental Common Stock Warrant Liability
SupplementalCommonStockWarrantLiability
484000
CY2011Q1 us-gaap Gross Profit
GrossProfit
357426
CY2011Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
848
CY2011Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
235206
CY2011Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1053268
CY2011Q1 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
56118
CY2011Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658
CY2011Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
174675
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-1030265
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-336827
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
244184
CY2011Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1032923
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-693438
CY2011Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1410694
CY2011Q1 us-gaap Operating Expenses
OperatingExpenses
1050864
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
627592
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2011Q1 isr Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
26008878 shares
CY2012Q1 us-gaap Gross Profit
GrossProfit
204220
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
144
CY2012Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
259010
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1113151
CY2012Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658
CY2012Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
3266
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-552886
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
209973
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
132237
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-555544
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-762859
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1317371
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
967079
CY2012Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
213095
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
575832
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2012Q1 isr Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
29316306 shares

Files In Submission

Name View Source Status
0001144204-12-029499-index-headers.html Edgar Link pending
0001144204-12-029499-index.html Edgar Link pending
0001144204-12-029499.txt Edgar Link pending
0001144204-12-029499-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
isr-20120331.xml Edgar Link completed
isr-20120331.xsd Edgar Link pending
isr-20120331_cal.xml Edgar Link unprocessable
isr-20120331_def.xml Edgar Link unprocessable
isr-20120331_lab.xml Edgar Link unprocessable
isr-20120331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v312572_10q.htm Edgar Link pending
v312572_ex31-1.htm Edgar Link pending
v312572_ex31-2.htm Edgar Link pending
v312572_ex32.htm Edgar Link pending